RhumbLine Advisers’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,625
| Closed | -$542K | – | 4410 |
|
|
2024
Q2 | $542K | Buy |
12,625
+3,018
| +31% | +$130K | ﹤0.01% | 2619 |
|
|
2024
Q1 | $407K | Buy |
9,607
+257
| +3% | +$10.9K | ﹤0.01% | 2792 |
|
|
2023
Q4 | $391K | Sell |
9,350
-406
| -4% | -$17K | ﹤0.01% | 2814 |
|
|
2023
Q3 | $368K | Buy |
9,756
+419
| +4% | +$15.8K | ﹤0.01% | 2808 |
|
|
2023
Q2 | $354K | Buy |
+9,337
| New | +$354K | ﹤0.01% | 2903 |
|